300146 Stock Overview
Develops and sells dietary supplements. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 2/6 |
| Past Performance | 2/6 |
| Financial Health | 5/6 |
| Dividends | 3/6 |
Byhealth Co., Ltd Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥11.70 |
| 52 Week High | CN¥17.77 |
| 52 Week Low | CN¥10.65 |
| Beta | 0.60 |
| 1 Month Change | 0.86% |
| 3 Month Change | 1.39% |
| 1 Year Change | -28.48% |
| 3 Year Change | -44.29% |
| 5 Year Change | -32.53% |
| Change since IPO | 91.31% |
Recent News & Updates
Recent updates
Byhealth's (SZSE:300146) Weak Earnings May Only Reveal A Part Of The Whole Picture
Mar 28
Byhealth Co., Ltd (SZSE:300146) Doing What It Can To Lift Shares
Mar 10Be Wary Of Byhealth (SZSE:300146) And Its Returns On Capital
Jan 07These 4 Measures Indicate That Byhealth (SZSE:300146) Is Using Debt Reasonably Well
Dec 03Byhealth Co., Ltd (SZSE:300146) Surges 32% Yet Its Low P/E Is No Reason For Excitement
Sep 30Byhealth (SZSE:300146) Will Want To Turn Around Its Return Trends
Sep 22Things Look Grim For Byhealth Co., Ltd (SZSE:300146) After Today's Downgrade
Aug 11Investors Don't See Light At End Of Byhealth Co., Ltd's (SZSE:300146) Tunnel
Jul 26Byhealth (SZSE:300146) Could Be Struggling To Allocate Capital
May 23We Think That There Are Issues Underlying Byhealth's (SZSE:300146) Earnings
Mar 25Byhealth Co., Ltd (SZSE:300146) Just Reported Earnings, And Analysts Cut Their Target Price
Mar 23Shareholder Returns
| 300146 | CN Personal Products | CN Market | |
|---|---|---|---|
| 7D | -1.4% | 0.6% | -1.1% |
| 1Y | -28.5% | -1.9% | 10.5% |
Return vs Industry: 300146 underperformed the CN Personal Products industry which returned -1.9% over the past year.
Return vs Market: 300146 underperformed the CN Market which returned 10.5% over the past year.
Price Volatility
| 300146 volatility | |
|---|---|
| 300146 Average Weekly Movement | 2.8% |
| Personal Products Industry Average Movement | 5.0% |
| Market Average Movement | 5.8% |
| 10% most volatile stocks in CN Market | 9.9% |
| 10% least volatile stocks in CN Market | 3.3% |
Stable Share Price: 300146 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 300146's weekly volatility (3%) has been stable over the past year.
Community vs My Fair Value
Create NarrativeSelect a narrative for quick price alerts from the community, or create your own.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2005 | 2,955 | Zhicheng Lin | www.by-health.com |
Byhealth Co., Ltd develops and sells dietary supplements. The company offers protein powder; collagen; bone health products, such as glucosamine, chondroitin and calcium tablets; and multivitamin products. It provides its products under the By-health, Jianli, Lifespace and other brand names through drug stores, supermarkets, maternal and child stores, distributors, retail terminals, and online channels.
Byhealth Co., Ltd Fundamentals Summary
| 300146 fundamental statistics | |
|---|---|
| Market cap | CN¥19.71b |
| Earnings (TTM) | CN¥652.83m |
| Revenue (TTM) | CN¥6.84b |
30.2x
P/E Ratio2.9x
P/S RatioIs 300146 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 300146 income statement (TTM) | |
|---|---|
| Revenue | CN¥6.84b |
| Cost of Revenue | CN¥2.32b |
| Gross Profit | CN¥4.52b |
| Other Expenses | CN¥3.86b |
| Earnings | CN¥652.83m |
Last Reported Earnings
Dec 31, 2024
Next Earnings Date
Apr 26, 2025
| Earnings per share (EPS) | 0.39 |
| Gross Margin | 66.06% |
| Net Profit Margin | 9.55% |
| Debt/Equity Ratio | 13.9% |
How did 300146 perform over the long term?
See historical performance and comparisonDividends
3.1%
Current Dividend Yield92%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/04/03 20:54 |
| End of Day Share Price | 2025/04/03 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Byhealth Co., Ltd is covered by 27 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| YANG QIAO | Changjiang Securities Co. LTD. |
| Wenbo Chen | China International Capital Corporation Limited |
| Haiyan Guo | China International Capital Corporation Limited |